Booth No.6C-18
CategoryIngredients
PavilionJapan Pavilion by JBPMA
Spera Nexus, Inc.
Booth No.：6C-18
Category：Ingredients
Pavilion：Japan Pavilion by JBPMA
Company Information
Email：
tamegai.hi@spera-nexus.co.jp
TEL： +81-3-3279-0454
Address： 103-0023
4-8-2, Nihombashi, Honcho, Chuo-ku, Tokyo JAPAN URL： https://www.spera-nexus.co.jp/en/
4-8-2, Nihombashi, Honcho, Chuo-ku, Tokyo JAPAN URL： https://www.spera-nexus.co.jp/en/
We “SPERA NEXUS” started the operation from 2021 by integration of “Iwaki” Pharmaceutical Chemicals Division and “Iwaki Seiyaku” Fine Chemicals Division”. We can archive crystalline evaluation, process optimization, commercial manufacturing and procurement of APIs and intermediates by own manufacturing and import. In 2023, our high-potency substance manufacturing facility started the operation.
We always think and act from the perspective of total optimization and always provide new value by improving our technology and quality of the service.
We always think and act from the perspective of total optimization and always provide new value by improving our technology and quality of the service.
Company information
| Address | 103-0023 4-8-2, Nihombashi, Honcho, Chuo-ku, Tokyo JAPAN |
|---|---|
| TEL | +81-3-3279-0454 |
| FAX | +81-3-3279-0410 |
| URL | https://www.spera-nexus.co.jp/en/ |
| tamegai.hi@spera-nexus.co.jp |
| Product Classification |
Apremilast Imatinib Mesilate Ezetimibe Edoxaban tosilate hydrate Olopatadine hydrochloride Canagliflozin hydrate Carfilzomib Guanfacine hydrochloride Zonisamide Zolpidem Tartrate Teneligliptin hydrobromide hydrate Nintedanib ethanesulfonate Pazopanib hydrochloride Paliperidone palmitate Bilastine Finasteride Pemafibrate Venlafaxine hydrochloride Macitentan Mirabegron |
|---|
Product introduction
ApremilastImatinib MesilateEzetimibeEdoxaban tosilate hydrateOlopatadine hydrochlorideCanagliflozin hydrateCarfilzomibGuanfacine hydrochlorideZonisamideZolpidem TartrateTeneligliptin hydrobromide hydrateNintedanib ethanesulfonatePazopanib hydrochloridePaliperidone palmitateBilastineFinasteridePemafibrateVenlafaxine hydrochlorideMacitentanMirabegronExhibitor's Presentation
〈Free of charge〉 Same day registration
If you would like to attend, please come directly to the seminar venue.
April 18(Thu.) 14:30 - 15:00 【6B】
Highly active pharmaceutical ingredients manufacturing facilities and contract synthesis.